Vigil Neuro
Meredith Jones has extensive work experience in contracts management. Meredith is currently working as an Associate Director of Contracts at Vigil Neuroscience since 2023. Prior to that, they served as a Senior Manager of Contracts at Kala Pharmaceuticals from 2018 to 2023. Meredith also worked as a Senior Contracts Manager at Sunovion Pharmaceuticals from 2016 to 2018, at Infinity Pharmaceuticals from 2011 to 2016, and at Pfizer from 2002 to 2011.
Meredith Jones holds a Bachelor of Arts degree in Biology/Biological Sciences from Brandeis University. Meredith also completed their Master of Business Administration degree in Business Administration and Management from the Isenberg School of Management, UMass Amherst.
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.